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Existing equations to calculate the estimated glomerular
filtration rate (eGFR) were derived from nondiabetic
Caucasian patients with chronic kidney disease. Here, we
developed formulas to more accurately predict the eGFR
in Chinese patients with type 2 diabetes and validated their
performance in 202 type 2 diabetic and 46 nondiabetic
individuals. Within the diabetic cohort, 135 were randomly
assigned to a training group, whereas the remaining
67 diabetic and all of the nondiabetic patients were assigned
to a validation group. Reference GFR was measured by
51Cr-EDTA plasma clearance. The new eGFR-estimating
formulas, derived using a stepwise regression model, were
compared with existing prediction equations in the
validation group. The formulas are: 313 (Age)0.494
(years) [SCr]1.059 (mg/dl) [Alb]þ 0.485 (g/dl) for men,
and 783 (Age)0.489 (years) [SCr]0.877 (mg/dl)
[SUN]0.150 (mg/dl) for women. Compared with existing
equations, the new formulas were more accurate and
precise in calculating eGFR in diabetic patients, but, similar
to other equations, were less accurate in the nondiabetic
cohort. Our newly developed equations are simple to use
and can be applied in routine clinical practice to calculate
eGFR in Chinese patients with type 2 diabetes.
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Diabetic nephropathy is the leading cause of end-stage renal
disease globally, accounting for 40% of patients receiving
renal replacement therapy each year.1 Asian diabetic patients
are at a higher risk of developing renal complications than
their Western counterparts.2 Early detection of nephropathy
enables prompt initiation of targeted therapy with the aim of
retarding the rate of renal deterioration.
Several international bodies, including the National
Kidney Foundation3 and the American Diabetes Associa-
tion,4 now recommend periodic monitoring of glomerular
filtration rate (GFR) in the regular consultation of diabetic
patients. A creatinine-based formula including the Modifica-
tion of Diet in Renal Disease (MDRD) study equations5,6
and the Cockcroft–Gault equation7 is advocated. The MDRD
study population consisted of mostly Caucasian subjects
with chronic kidney disease (CKD), with Asians and other
minority ethnic groups contributing o8%. The Cockcroft–-
Gault equation was established more than 30 years ago in
male-only subjects with close-to-normal renal function.
Given that muscle mass, which is a major determinant for
the generation of creatinine, differs between the Chinese and
the Caucasians, the performance of the existing equations
may be compromised when used in the Chinese. Indeed, few
studies have addressed the validity of either equation in the
Chinese population.8
The objective of this study was to develop a set of accurate,
simple, and clinically practical formulae to estimate GFR
in Chinese subjects with type 2 diabetes, and to validate
their performance using separate samples of diabetic and
nondiabetic subjects. In addition, we compared the perfor-
mance of our new equations with published GFR-estimating
equations.
RESULTS
A total of 202 subjects with type 2 diabetes and 46
nondiabetic subjects were recruited. In the diabetic group,
135 subjects were assigned to the training group. The
remaining 67 diabetic and 46 nondiabetic subjects were
assigned to the validation group. The demographic and
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clinical characteristics of the diabetic and nondiabetic
subjects are summarized in Appendix 1. Among subjects
with diabetes, 87.6% were treated with metformin, 66.3 %
with sulphonylurea, 7.9% with acarbose, and 28.7% with
insulin within the last 12 months. The mean (±s.d.)
measured GFR was 76±27ml/min per 1.73m2 in the
diabetic group and 93±19ml/min per 1.73m2 in the
nondiabetic group.
Figure 1 shows the relation of estimated GFR on the basis
of 24-h urinary creatinine clearance and Cockcroft–Gault
equation with measured GFR in the diabetic group. The
Cockcroft–Gault equation underestimated measured GFR
with mean discrepancy—15.4ml/min per 1.73m2, whereas
urinary creatinine clearance underestimated measured
GFR—20.1ml/min per 1.73m2. Using the training group,
we modified these equations using corrective factors that best
fitted 51Cr-EDTA plasma clearance as:
(1) 1.16Cockcroft–Gault equation (modified Cockcroft–-
Gault)
(2) 1.05 creatinine clearance (modified creatinine clearance)
We constructed GFR-estimating equations using the
training group of 135 diabetic subjects. All demographic,
clinical, and laboratory variables were incorporated into a
linear regression model. Variables that correlated significantly
with measured GFR (Pp0.01) in both genders included age,
systolic blood pressure, serum creatinine concentration,
serum urea nitrogen (SUN) level, hemoglobin, hematocrit,
and red cell distribution width. Besides, waist–hip ratio,
serum potassium, serum phosphate, triglyceride level, and
red cell count were significant in women, whereas HbA1c and
serum albumin level were significant in men. The natural
logarithms of variables that correlated with measured GFR
and had a P-value o0.005 were calculated, and multiple
regression equation was established by stepwise regression
model. The equations of the natural logarithm of GFR were
reexpressed in original units by taking a natural anti-
logarithm function on both sides.
Three models in males were developed using common
clinical and biochemical parameters:
(1) univariate model included only serum creatinine;
(2) the bivariate model included serum creatinine and age;
and
(3) the trivariate model included serum creatinine, serum
albumin, and age
In females, four models were developed:
(1) univariate model included serum creatinine;
(2) the bivariate model included serum creatinine and age;
(3) the trivariate model included serum creatinine, age, and
SUN; and
(4) the four-variable model included serum creatinine, age,
SUN, and red cell distribution width
The univariate model in both genders explained o90%
variance of the measured GFR (R2o90%). The four-variable
model in females improved correlation insignificantly, but
one more blood specimen was required to measure the
hematological variable. Taking these factors into considera-
tion, two GFR-estimating formulae (Chinese Diabetic Kidney
Disease (CDKD) formula) relevant to Chinese patients with
type 2 diabetes were developed. The three-variable equation
took into account age, serum creatinine, and serum albumin
in men or SUN in women. The simplified version required
age and serum creatinine as the only variables. The final
formulae are as follows:
Simplified CDKD formula (ml/min per 1.73m2)
(for men)¼ 660 (Age)0.495 (years) [SCr]1.097 (mg/dl)
(for women)¼ 633 (Age)0.542 (years) [SCr]1.012 (mg/dl)
Three-variable CDKD (ml/min per 1.73m2)
(for men)¼ 313 (Age)0.494 [SCr]1.059 (mg/dl)
[Alb]þ 0.485 (g/dl)
(for women)¼ 783 (Age)0.489 [SCr]0.877 (mg/dl)
[SUN]0.150 (mg/dl)
The two CKDK formulae together with four commonly
used GFR-estimating equations were applied to the diabetic
and nondiabetic validation groups. In the validation group of
62 diabetic subjects with a mean GFR of 73±26ml/min per
1.73m2, both the three-variable CDKD and simplified CDKD
formulae slightly overestimated the measured GFR (Table 1).
Both CDKD formulae yielded a more accurate prediction of
GFR than did the other methods in terms of R2 statistics and
size of error. In 50% of diabetic patients, the absolute
difference between estimated and measured GFR for both
three-variable CDKD and simplified CDKD equations was
o5%. The corresponding mean absolute errors for the three-
variable and simplified CDKD formulae were 0.97 and
0.96ml/min per 1.73m2, respectively. Both the six-variable
MDRD and abbreviated MDRD study equations under-
estimated true GFR by a mean of 4.00 and 6.68ml/min per
1.73m2, respectively.
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Figure 1 |Relation of (a) 24h urine creatinine clearance and
(b) estimation by the Cockcroft–Gault equation to measured
glomerular filtration rate (GFR) by 51Cr EDTA plasma
clearance.
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Table 2 shows the validation of these equations in the
nondiabetic group. All the subjects in this group had a
measured GFR ofX60ml/min per 1.73m2. All of the models
showed worse performance in the nondiabetic group
compared with the diabetic group. The simplified CDKD
formula was the most accurate in the 50th percentile, whereas
the modified Cockcroft–Gault equation performed best in the
90th percentile.
Using the Kidney Disease Outcome Quality Initiative
classification of CKD, we validated the sensitivity and
specificity of the new and existing GFR-estimating equations
in categorizing the stages of renal disease in the diabetic
cohort (Table 3). Both CDKD formulae correctly identified
CKD across stages 1–3 in B80% of patients but sensitivity
decreased to 75% with stage 4 CKD. Less than two-thirds of
stage 1 CKD could be identified by either of the six-variable
and abbreviated MDRD study equations. However, the
MDRD study equations were more sensitive than either
CDKD formulae in detecting stage 4 disease.
DISCUSSION
GFR is the gold standard for measuring renal function.
However, measurement of GFR is costly and time consuming,
and therefore GFR-predicting equations provide a simple and
rapid method for monitoring and treatment purposes.
Estimation of GFR in clinical practice relies on serum
creatinine concentration. Creatinine is mainly derived from
metabolism of creatine in muscle and its generation is
directly proportional to the total muscle mass. Besides, serum
creatinine concentration is affected by ethnicity, age, and
gender. Muscle mass in the American Asians is less than that
of the Caucasians, whereas muscle mass in the African
Americans is higher than that of the Caucasians.9 The
Chinese have lower muscle mass and reduced creatinine
production than does the Western population because of
differences in the genetic makeup, dietary habits, and levels of
physical activity. Lower muscle mass causes lower serum
creatinine concentration at any level of GFR. For this reason,
creatinine-based GFR-estimating equations that were derived
from the Caucasian population may be less accurate when
applied in different ethnic groups. In this study, we have
developed new formulae to estimate GFR in Chinese patients
with type 2 diabetes and comparison was made with
published equations.
The derived three-variable CDKD and simplified CDKD
formulae were validated in separate cohorts of diabetic and
Table 1 | Validation of glomerular filtration rate (GFR) estimating equations compared with measured GFR by plasma clearance
of 51Cr-edetate method in Chinese type 2 diabetic patients
Accuracy
Percentile Accuracy % within
Mean GFRa Correlation 50th 75th 90th Bias Precision CRMSE 30% 50%
Measured 73±26 (56–94) — — — — — —
CDKD 74±25 (54–93) 0.926 4.33 9.65 18.2 0.97 9.87 9.92 94.0 100
Simplified CDKD 74±25 (54–94) 0.926 4.93 10.0 17.4 0.96 9.80 9.85 94.0 100
MDRD 69±23 (51–85) 0.914 6.92 10.9 17.1 4.00 10.5 11.3 94.0 100
Abbreviated MDRD 66±22 (50–81) 0.908 7.09 14.1 21.8 6.68 11.1 12.9 92.5 100
Modified Cockcroft–Gaultb 74±31 (57–88) 0.894 6.37 13.8 21.3 0.87 12.0 12.0 92.5 98.5
Modified creatinine clearanceb 74±28 (55–94) 0.798 11.5 16.9 21.5 1.24 17.2 17.2 77.6 97.0
Abbreviations: BSA, body surface area; CDKD, Chinese Diabetes Kidney Disease; CRMSE, combined root mean squared error; MDRD, Modification of Diet in Renal Disease.
aMean GFR expressed as mean±s.d. (interquartile range), ml/min per 1.73m2.
bAdjusted for BSA of 1.73m2.
Table 2 | Validation of glomerular filtration rate (GFR) estimating equations compared with measured GFR by plasma clearance
of 51Cr-edetate method in Chinese nondiabetic subjects
Accuracy
Percentile Accuracy % within
Mean GFRa Correlation 50th 75th 90th Bias Precision CRMSE 30% 50%
Measured 93±18 (78–103) — — — — — —
CDKD 98±23 (81–111) 0.766 7.77 14.7 23.6 4.23 14.5 15.1 93.3 100
Simplified CDKD 97±22 (82–109) 0.787 6.93 15.0 22.6 3.60 13.4 13.9 93.3 100
MDRD 89±17 (79–96) 0.709 8.27 16.7 21.6 3.90 13.3 13.8 100 100
Abbreviated MDRD 85±16 (75–92) 0.757 9.35 15.9 22.8 8.38 11.8 14.5 100 100
Modified Cockcroft–Gaultb 95±26 (80–106) 0.782 10.2 14.9 21.1 1.70 16.6 16.7 91.1 97.8
Modified creatinine clearanceb 99±28 (82–111) 0.319 17.5 28.3 47.4 5.17 28.0 28.5 71.1 93.3
Abbreviations: BSA, body surface area; CDKD, Chinese Diabetes Kidney Disease; CRMSE, combined root mean squared error; MDRD, Modification of Diet in Renal Disease.
aMean GFR expressed as mean±s.d. (interquartile range), ml/min per 1.73m2.
bAdjusted for BSA of 1.73m2.
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nondiabetic subjects. The new formulae generated a slightly
more accurate prediction of GFR in the diabetic group with a
wide range of renal function than did the nondiabetic group
with GFR460ml/min per 1.73m2. In the diabetic group, the
two CDKD formulae had the best performance index in
terms of accuracy and precision. The other models in
decreasing order of performance were the six-variable MDRD
equation, abbreviated MDRD equation, modified Cock-
croft–Gault equation, and modified creatinine clearance.
The Cockcroft–Gault formula, published in 1976, was
derived from 249 male subjects with a mean GFR (±s.d.) of
73±21ml/min per 1.73m2, using 24 h urinary creatinine
clearance as the reference method.7 Since their introduction
by Levey et al.5,6 in 1999, however, the MDRD study
equations have largely superseded the Cockcroft–Gault
formula in GFR prediction in both clinical and research
settings. The MDRD study equations were developed in 1628
patients, mean GFR (±s.d.) 40±21ml/min per 1.73m2,
who had renal impairment of different etiology, including
glomerulopathy in 32%, polycystic kidney disease in
22%, tubulointerstitial disease in 7%, and other unknown
causes in 40%.
Several studies have reported the underestimation of GFR
using the MDRD study equations compared with the
measured GFR.10,11 In a validation study by Rule et al.10
involving 900 patients, of whom one-third had CKD, the
abbreviated MDRD study equation underestimated GFR by
6.2% in patients with CKD and 8.5% in those with preserved
renal function. In addition, they observed that GFR
estimation by the abbreviated MDRD study equation was
less accurate and less precise in healthy subjects than in
patients with CKD. This is not surprising as the MDRD
equations were derived from subjects with renal impairment
and the factors of blood urea and albumin may not correlate
well in subjects with normal renal function. Indeed,
misclassification of CKD in individuals who have normal
renal function has been a major weakness of the MDRD
study equations as it may lead to unnecessary investigations
and treatment. Rigalleau et al.11 compared the performance
of the abbreviated MDRD study equation and Cockcroft–-
Gault equation in 160 patients with diabetes. Using the renal
clearance of 51Cr-EDTA as a reference standard, they found
that the former underestimated and the latter overestimated
the measured GFR. In that study, the mean difference (mean
percentage difference) between measured and estimated GFR
by the abbreviated MDRD study equation was 7.5ml/min per
1.73m2 (13%) and that by the Cockcroft–Gault equation was
6.5ml/min per 1.73m2 (11%). Recently, Zuo et al.8 evaluated
the performance of the GFR-estimating equations, compar-
ing against plasma clearance of 99mTc-DTPA, in a group of
Chinese patients with CKD. Similar to studies conducted in
the Caucasians, Zuo et al. also observed that the MDRD
equation underestimated GFR in subjects with near-normal
renal function. In our study, we confirmed underestimation
of the measured GFR using the abbreviated MDRD study
equation by 6.7ml/min per 1.73m2, whereas the modified
Cockcroft and Gault equation, the three-variable CDKD, and
simplified CDKD formulae slightly overestimated GFR with
corresponding mean differences of 0.87, 0.97, and 0.96ml/
min per 1.73m2, respectively, in the diabetic cohort (n¼ 67).
The CDKD formulae were more sensitive at identifying
early stages of CKD than were the MDRD study equations.
On the contrary, the MDRD study equations performed
better than did the CDKD formulae in detecting stage 4
CKD. This is an important shortcoming of the new GFR-
estimating formulae. Few subjects recruited for development
of the new equations had reduced GFR. Indeed, the mean
GFR (±s.d.) was 76±26ml/min per 1.73m2, and the highest
serum creatinine was 118 mmol/l in the diabetic cohort. This
explains the better performance of the new equations in
identifying patients with stage 1/2 CKD than higher stages.
Validation in other populations, in particular Chinese
diabetic and nondiabetic subjects with more severe renal
impairment, is required to assess the adequacy of the new
formulae in estimating GFR across a wider range of renal
function.
This study has several limitations. First, direct comparison
of the MDRD equations and the newly developed formulae
may be biased by the differences in the reference markers
used. In this study, GFR was determined using plasma
clearance of 51Cr-EDTA, whereas iothalamate was the
reference marker used in the MDRD study. This partly
explained the improved accuracy of the new formulae
compared with the MDRD study equations. Second,
measurement of serum creatinine was not calibrated to the
MDRD standard. This may constitute a bias against the
MDRD study equations in the comparison analysis. Third,
there was an underrepresentation of diabetic subjects
Table 3 | Sensitivity and specificity of different equations for
stages of chronic kidney disease in Chinese type 2 diabetic
patients
Stage 1
(n=66)
Stage 2
(n=83)
Stage 3
(n=45)
Stage 4/5
(n=8)
Three-variable CDKD
Sensitivity 78.8 80.7 82.2 75.0
Specificity 94.1 84.9 93.6 99.0
Simplified CDKD
Sensitivity 80.3 81.9 84.4 75.0
Specificity 94.9 84.0 93.0 99.5
Six-variable MDRD
Sensitivity 62.1 84.3 84.4 100
Specificity 97.8 76.5 93.6 97.9
Abbreviated MDRD
Sensitivity 48.5 73.5 88.9 100
Specificity 97.8 69.7 87.9 98.5
Modified
Cockcroft–Gault
Sensitivity 81.8 77.1 77.8 62.5
Specificity 94.1 84.0 91.1 98.5
Abbreviation: CDKD, Chinese Diabetes Kidney Disease.
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with hyperfiltration, which is an early subclinical sign of
diabetic nephropathy and reflects underlying glomerular
hypertension. In this cohort, diabetic patients with GFR
4120ml/min per 1.73m2 were o3%, and therefore the
performance of the new formulae on hyperfiltration could
not be fully examined.
In this study, we have established two simple and clinically
practical formulae to predict GFR in Chinese patients with type
2 diabetes and validated the performance of these formulae. Age
and serum creatinine were the two most important independent
predictors for renal function. Compared with other published
prediction equations, the CDKD formulae were less biased, more
precise, and accurate. Both formulae also performed well in
nondiabetic subjects, although the overall performance of these
formulae was better in patients with diabetes.
MATERIALS AND METHODS
Subjects
Patients were recruited from either the Diabetes Clinic or Specialist
Outpatient Department at the Pamela Youde Nethersole Eastern
Hospital. All patients were aged between 26 and 85 years. Patients
with type 2 diabetes were treated with either oral antidiabetic drugs
and/or insulin within the past 12 months. Patients recruited from
the Specialist Outpatient Department had no known history of
diabetes and were not taking antidiabetic medications. These
patients had fasting plasma glucose o6.0mmol/l on the day of
GFR measurement. The Clinical Research Ethics Committee of the
Pamela Youde Nethersole Eastern Hospital approved this study, and
all patients gave written informed consent before the study.
Patients attended the Department of Nuclear Medicine early in
the morning after an overnight fast for GFR measurement. A 24-h
urinary collection was started on the previous day. Patients were
instructed to collect all urine samples after voiding the first sample
in the morning and to complete the collection by including the first
voided urine sample the next morning. Body height in centimeters
(cm), body weight in kilograms (kg), and waist and hip circum-
ferences (cm) were measured. Blood pressure was measured in the
sitting position after 15min of rest using the Critikon Dinamapp
Compact Monitor (Model T, Berkshire, UK).
Laboratory measurements
Both serum and urinary creatinine concentrations were measured by
the kinetic rate alkaline picrate (Jaffe) method using an Aeroset
spectrophotometric analyzer (Abbort Laboratories, Abbott Park, IL,
USA). GFR was analyzed by the slope-intercept method of 51Cr-EDTA
plasma clearance, following the guideline recommended in the
report of the Radionuclides in Nephrourology Committee on Renal
Clearance.12 The patient was requested not to take coffee, tea, coke,
or any diuretic drug and to drink only water and have a light
breakfast and lunch during the test. An oral water load (400ml) was
given to initiate an appropriate urine flow. Venous blood was
collected in a heparinized collecting tube for background counting.
After a single bolus injection of 3.7MBq 51Cr-EDTA (3.7MBq/ml at
the reference time, CJ13P, Amersham, Buckinghamshire, UK), two
venous blood samples were drawn from the other arm at 120 and
240min after injection. Finally, the 51Cr radioactivity was measured
in duplicate of 1-ml plasma aliquots using a gamma counter with
energy windows set at 240–400 keV (Cobra Quantum 5010, Packard,
CT, USA). The measured GFR was adjusted to a nominal body
surface area (BSA) for a standard man taken as 1.73m2. Values of
BSA were estimated from the patient’s height and weight using the
Gehan and George formula13 (Appendix 2). The adjusted GFR was
corrected by the Bro¨chner-Montensen14 quadratic equation to
compensate for the fast exponential compartment of the plasma
disappearance curve (Appendix 3). Measured urinary creatinine and
creatinine clearance derived by the Cockcroft–Gault equation were
normalized to standard BSA using the Gehan and George formula.
Statistical analysis
All data are expressed as mean±s.d., or median (interquartile range),
or number (%), as appropriate. The relationships of renal function to
other baseline characteristics and biochemical parameters were
assessed by using contingency tables, t-test, and analysis of variance
and linear regression, whenever appropriate. A P-value o0.01 was
considered statistically significant. SPSS 10.0 for Windows (SPSS,
Chicago, IL, USA) was used for all statistical calculations.
Development of new GFR-estimating formula
Two-thirds of type 2 diabetic patients were randomly assigned to the
training group in which the GFR-estimating equations were established.
The remaining one-third of diabetic patients and all nondiabetic patients
were used to validate the performance of the new equations.
In this study, the new GFR-estimating formulae took into account
the simplicity and practicality of the measured parameters. Collection
of 24-h urine samples is cumbersome and often incomplete, especially
in the elderly population. Thus, urine parameters were excluded from
the model. Only demographic variables and serum biochemical
parameters measured in routine practice were included in the
regression model. The former included body weight, height, gender,
age, duration of diabetes, and mean systolic and diastolic blood
pressures. Laboratory measurements included the fasting plasma
glucose, HbA1c, SUN, creatinine, albumin, sodium, potassium, calcium,
and phosphate levels. Studies have shown that hematocrit15 and
anemia16 are independent risk factors for CKD, and white blood
cells17 and platelet count18 may have a role in diabetic microvascular
and macrovascular complications. Thus, the hemoglobin level,
hematocrit level, red blood cell count, red blood cell indices,
white blood cell count, platelet count, and mean platelet volume were
also included.
A P-valueo0.005 was used as the criterion for entry of a variable
into the model. Selected variables were logarithmically transformed.
The prediction formulae were developed by stepwise regression
method. The multiple regressions on log-transformed data were
reexpressed in original units and adjusted to achieve the best
correlation with the measured GFR.
Validation and comparison of different equations
The new formulae were compared with four other common
GFR-estimating equations:
(1) Cockcroft–Gault equation normalized by BSA (ml/min
per 1.73m2):7
(a) For men:
CrCl ¼ ð140 Age ðyearsÞÞBW ðkgÞ88:41:73 ðm
2Þ
72 ½SCr ðmmol=lÞBSA ðm2Þ
(b) For women:
CrCl ¼ ð140 Age ðyearsÞÞBW ðkgÞ88:41:73 ðm
2Þ0:85
72 ½SCr ðmmol=lÞBSA ðm2Þ
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(2) Urinary creatinine clearance normalized by BSA (ml/min
per 1.73m2):
CrCl ¼ ½UCr ðmmol=24hÞ100010001:73 ðm
2Þ
½SCr ðmmol=lÞ1400BSA ðm2Þ
(3) Six-variable MDRD study equation (ml/min per 1.73m2):5
(a) For men:
GFR ¼ 170½SCr0:999 ðmg=dlÞðAgeÞ0:176ðyearsÞ
½SUN0:170ðmg=dlÞ½Alb0:318 ðg=dlÞ
(b) For women:
GFR ¼ 129:54½SCr0:999ðmg=dlÞðAgeÞ0:176 ðyearsÞ
½SUN0:170 ðmg=dlÞ½Alb0:318ðg=dlÞ
(4) Abbreviated MDRD study formula (ml/min per 1.73m2):6
(a) For men:
GFR ¼ 186½SCr1:154ðmg=dlÞðAgeÞ0:203ðyearsÞ
(b) For women:
GFR ¼ 1860:742½SCr1:154ðmg=dlÞðAgeÞ0:203ðyearsÞ
To approximate GFR using urinary creatinine clearance and the
Cockcroft–Gault equation, multiplicative constants were calculated
in the training set using regression analysis.
The estimated GFR values were compared with measured GFR
in the validation sample to evaluate the performance of the GFR-
estimating equations. The correlation coefficient was used to assess
the overall fit of the model. The value of R statistics ranges from 0 to
1.0 and is a measure of the percentage variation in the actual GFR that
can be accounted for by the prediction equation. Higher values of R
statistics indicate greater precision. The 50th, 75th, and 90th percentiles
of the distribution of percentage absolute difference between measured
and estimated GFR assess the size of errors that occurred with the
model. Bias is a measure of systemic error and was defined by the mean
difference between measured and estimated GFR. Precision was defined
as the s.d. of the difference between measured and estimated GFR.
Accuracy is defined as the proximity of the estimation compared with
the reference and is a measure encompassing both precision and bias.
The measure of accuracy was calculated using two methods: combined
root mean squared error, and percentage of GFR within 30% (P30%)
or 50% (P50%) of measured GFR.
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Appendix 2
Gehan and George13 formula:
BSA ðm2Þ ¼ 0:0235ðWÞ0:515ðHÞ0:422
whereW is the patient’s body weight in kg and H is the height
in cm
Appendix 3
Bro¨chner-Montensen14 quadratic equation:
GFR ¼ 0:99GFRBSA  0:0012GFR2BSA
where GFR is the clearance corrected for the first exponential
and GFRBSA is the noncorrected clearance.
Appendix 1 | Summary of physical and biochemical
parameters in Chinese subjects with or without type 2
diabetes mellitus (T2DM)a
Patient group T2DM Non-T2DM
Number of subjects 202 46
Years of diabetes (years) 10.0±7.3 0
Male gender n (%) 102 (50%) 24 (52%)
Age (years) 59.9±10.5 54.7±12.9
Weight (kg) 65.6±12.3 63.2±14.6
Height (cm) 160±8.8 160±8.5
Body surface area (m2) 1.72±0.19 1.69±0.22
Waist–hip ratio 0.94±0.06 0.89±0.09
Body mass index (kg/m2) 25.6±3.8 24.5±4.23
Systolic blood pressure (mmHg) 144±22.6 133±22.8
Diastolic blood pressure (mmHg) 80±10.6 79±11.9
Measured GFR (ml/min per 1.73m2) 75.9±26.6 92.5±18.5
Fasting plasma glucose (mmol/l) 7.6±2.03 5.0±0.42
HbA1c (%) 7.5±1.06 5.5±0.48
Urine creatinine (mmol per day) 9.67±3.33 10.6±4.03
Serum sodium (mmol per l) 141±2.2 141.4±3.8
Serum potassium (mmol per l) 4.3±0.4 4.1±0.4
Serum urea (mmol per l) 7.0±3.3 5.3±1.2
Serum creatinine (mmol per l) 91 (74–118) 76 (68–89)
Serum albumin (g per l) 45.4±3.8 46.9±2.5
Serum calcium (mmol per l) 2.36±0.12 2.43±0.14
Serum phosphate (mmol per l) 1.16±0.18 1.11±0.15
Fasting total cholesterol (mmol per l) 5.13±1.0 5.52±1.1
Fasting triglycerides (mmol per l) 1.56 (1.06–2.08) 1.28 (1.21–1.68)
HDL-cholesterol (mmol per l) 1.26±0.35 1.47±0.36
LDL-cholesterol (mmol per l) 3.04±0.78 3.41±0.95
White blood cells (109 per l) 6.7±1.8 6.1±1.6
Red blood cells (1012 per l) 4.53±0.61 4.7±0.45
Platelets (109 per l) 244±62.1 227±52.1
Hemoglobin (g per dl) 13.4±1.64 14.3±1.30
Hematocrit (%) 39.6±4.7 42.1±3.8
Abbreviations: GFR, glomerular filtration rate; HDL, high-density lipoprotein;
LDL, low-density lipoprotein; T2DM, type 2 diabetes mellitus.
aMean±s.d. or n (%) or median (interquartile range).
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